THE IMPACT OF GASTRO-INTESTINAL INVOLVEMENT AT DIAGNOSIS ON OVERALL SURVIVAL IN PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS (LCH) - A RETROSPECTIVE ANALYSIS OF DAL-HX, LCH-I, LCH-II, AND LCH-III

被引：0

作者：

Potschger, Ulrike ^{[1
]}

Thiem, Elfriede ^{[1
]}

Arico, Maurizio ^{[2
]}

Astigarraga, Itziar ^{[3
]}

Braier, Jorge ^{[4
]}

Donadieu, Jean ^{[5
]}

Grois, Nicole ^{[1
]}

Gadner, Helmut ^{[1
]}

Henter, Jan-Inge ^{[6
]}

Janka-Schaub, G. ^{[7
]}

McClain, Ken ^{[8
]}

Weitzman, Sheila ^{[9
]}

Windebank, Kevin ^{[10
]}

Minkov, Milen ^{[1
]}

van den Bos, Cor ^{[11
]}

Abla, Oussama ^{[9
]}

机构：

[1] Childrens Canc Res Inst, Vienna, Austria

[2] Univ A Meyer, Florence, Italy

[3] Hosp Cruces, Baracaldo, Spain

[4] Hosp Garrahan, Buenos Aires, DF, Argentina

[5] Hop Trousseau, Paris, France

[6] Karolinska Inst, Stockholm, Sweden

[7] Univ Klinikum Hamburg Eppendorf, Hamburg, Germany

[8] Texas Childrens Clin Hosp, Houston, TX USA

[9] Hosp Sick Children, Toronto, ON, Canada

[10] Sir James Spence Inst, Newcastle Upon Tyne, Tyne & Wear, England

[11] Prinses Maxima Ctr, Utrecht, Netherlands

来源：

PEDIATRIC BLOOD & CANCER | 2020年 / 67卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：S25 / S25

页数：1

共 7 条

[1] ORGAN DYSFUNCTION IN LANGERHANS CELL HISTIOCYTOSIS (LCH) - TREATMENT RESULTS IN DAL-HX 83 STUDY
HEITGER, A
GOBEL, U
RITTER, J
GADNER, H
[J]. MEDICAL AND PEDIATRIC ONCOLOGY, 1988, 16 (06): : 432 - 432
[2] FACTORS ASSOCIATED WITH SHORT-TERM OUTCOME IN PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS - A RETROSPECTIVE ANALYSIS OF THE DAL-HX, LCH I-III STUDY COHORTS
Potschger, Ulrike
Abla, Oussama
Astigarraga, Itziar
Braier, Jorge
Donadieu, Jean
Henter, Jan-Inge
Lehrnbecher, Thomas
Rodriguez-Galindo, Carlos
Sieni, Elena
Thiem, Elfriede
Nanduri, Vasanta
van den Bos, Cor
Minkov, Milen
[J]. PEDIATRIC BLOOD & CANCER, 2023, 70 : S37 - S38
[3] DOES EARLY CHEMOTHERAPY INFLUENCE THE NATURAL COURSE OF DISEASE IN LANGERHANS CELL HISTIOCYTOSIS (LCH) - RESULTS OF THE DAL-HX 83 STUDY
GADNER, H
HEITGER, A
GATTERER, I
GOBEL, U
JANKASCHAUB, GE
KUHL, J
RITTER, J
[J]. BLUT, 1988, 57 (04): : 222 - 222
[4] LATE PRESENTATION PREDICTS ENDOCRINE DYSFUNCTION IN PATIENTS WITH LANGERHANS CELL HISTIOCYTOSIS (LCH) - A RETROSPECTIVE ANALYSIS OF THE WEST OF SCOTLAND LCH SERVICE 1998-2012
Ronghe, M.
Coyte, A.
Murphy, D.
Sastry, J.
Ahmed, F.
Shaikh, G.
[J]. PEDIATRIC BLOOD & CANCER, 2014, 61 : S298 - S298
[5] EVENT FREE SURVIVAL OF PATIENTS WITH MULTISYSTEM-RISK LANGERHANS CELL HISTIOCYTOSIS IS SUBOPTIMAL WITH LCH-III PROTOCOL: 8-YEARS CHANDIGARH, INDIA EXPERIENCE
Totadri, S.
Bansal, D.
Trehan, A.
Srinivasan, R.
Varma, N.
Kakkar, N.
Saxena, A. K.
Bhatia, P.
[J]. PEDIATRIC BLOOD & CANCER, 2015, 62 : S222 - S222
[6] Impact of reactivation on the long-term outcome of multi-system Langerhans cell histiocytosis (LCH) patients: Analysis of JLSG-96 protocol study
Morimoto, Akira
Ikushima, Satoshi
Kinugawa, Naoko
Ishii, Eiichi
Kohdera, Urara
Sako, Masahiro
Fujimoto, Junichiro
Bessho, Fumio
Horibe, Keizo
Tsunematsu, Yukiko
Imashuku, Shinsaku
[J]. PEDIATRIC BLOOD & CANCER, 2007, 48 (07) : 758 - 759
[7] EARLY MORTALITY IN LANGERHANS CELL HISTIOCYTOSIS III (LCH-III) TRIAL SUGGESTS SOME PATIENTS REQUIRE MORE EFFECTIVE THERAPY EVEN BEFORE THE 1ST RESPONSE ASSESSMENT POINT AT 6 WEEKS
Visser, Johannes
Potschger, Ulrike
Thiem, Elfriede
Minkov, Milen
Arico, Maurizio
Astigarraga, Itziar
Braier, Jorge
Donadieu, Jean
Grois, Nicole
Gadner, Helmut
Henter, Jan-Inge
Janka-Schaub, Gritta
McClain, Kenneth
Weitzman, Sheila
Windebank, Kevin
Ladisch, Stephan
[J]. PEDIATRIC BLOOD & CANCER, 2020, 67 : S16 - S16

← 1 →